Comparative Pharmacology
Head-to-head clinical analysis: METHADOSE versus PHENERGAN VC W CODEINE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: METHADOSE versus PHENERGAN VC W CODEINE.
METHADOSE vs PHENERGAN VC W/ CODEINE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Methadone is a mu-opioid receptor agonist; it also acts as an NMDA receptor antagonist and inhibits serotonin and norepinephrine reuptake, contributing to its analgesic and detoxification effects. It has a long half-life and reduces opioid craving and withdrawal symptoms.
Phenergan VC w/ Codeine combines codeine (opioid agonist, mu-receptor), promethazine (histamine H1 antagonist, anticholinergic, sedative), and phenylephrine (alpha-1 adrenergic agonist). Codeine is metabolized to morphine for analgesia and antitussive effects; promethazine suppresses cough via central nervous system depression; phenylephrine causes vasoconstriction to relieve congestion.
Oral: 20-40 mg once daily, titrated to effect; for opioid dependence, typical maintenance 80-120 mg/day. IV: 2.5-10 mg every 8-12 hours.
1 to 2 teaspoonfuls (5-10 mL) orally every 4 to 6 hours as needed. Maximum 4 doses in 24 hours.
None Documented
None Documented
Terminal elimination half-life range: 8–59 hours (mean ~20–35 hours). In chronic use, half-life may increase due to accumulation. Context: The long half-life supports once-daily dosing for opioid dependence but requires careful titration to avoid accumulation.
Codeine: terminal half-life ~3 hours (range 2.5-4.5 h) in adults; extended in renal impairment. Promethazine: terminal half-life ~10-14 hours (range 7-20 h) in adults; prolonged in elderly and hepatic impairment.
Primarily renal (approximately 80%) as inactive metabolites, with about 20% eliminated via feces. Less than 10% excreted unchanged.
Codeine: renal elimination of metabolites (codeine-6-glucuronide, norcodeine, morphine, morphine-3-glucuronide, morphine-6-glucuronide); ~90% excreted in urine, <10% in feces. Promethazine: renal and biliary elimination as metabolites and unchanged drug; ~70-80% in urine, <20% in feces.
Category C
Category D/X
Opioid Agonist
Opioid Agonist